Personal hygiene compositions

Description

1 / 59 Personal Hygiene Compositions - Cross-reference to Related Orders

[0001] This application claims the benefit of priority over U.S. Patent Application No. 63 / 493,404, filed March 31, 2023, entitled Personal Care Compositions, the contents of which are incorporated herein in full for all purposes. FOUNDATION

[0002] Several underarm products contain metallic salts, such as aluminum salts. However, consumer preference for products without metallic salts has created a need for new deodorant formulations that provide protection against... SU

[0003] The present invention is directed to a deodorant composition containing xanthan gum; a glycerin ester and a C14-22 fatty acid; polyol; and an alkaline salt of a C14-22 fatty acid.

[0004] Other embodiments of the present invention include a co-heptylglycerin; xanthan gum; glyceryl monolaurate; a co-polyol

[0005] Other embodiments of the present invention include co-methylheptylglycerin in an amount ranging from about 0.5% by weight to about 2.5% by weight based on the total weight of the deodorant composition; xanthan gum in an amount ranging from about 0.1% and Petition 870250084517, dated 09 / 19 / 2025, page 15 / 86 2 / 59 deodorant; sodium stearate in an amount ranging from about 1% by weight to about 12% by weight based on the total weight of the deodorant composition; and from about 0.25% by weight to about 2.25% by weight based on the total weight of the composition.

[0006] Other embodiments of the present invention include a method of preventing bad breath, comprising the application of one or more of the following:

[0007] Other embodiments of the present invention include a method for manufacturing a deodorant composition comprising: a) mixing u polyol or polyols and adding u

[0008] Other areas of applicability of the present invention will become apparent from the detailed description provided below. It should be considered for illustrative purposes only and is not intended to limit the scope of the invention.

[0009] A list of examples of non-limiting modalities is provided below.

[0010] According to modality 1, a personal hygiene composition is provided comprising: optional alkylglyceryl ether; go u polyol containing glycerin; and Petition 870250084517, dated 09 / 19 / 2025, page 16 / 86 3 / 59 an alkaline salt of a C14-22 fatty acid.

[0011] According to embodiment 2, a personal hygiene composition is provided according to embodiment 1, wherein the alkyl glyceryl ether comprises methylheptylglycerin and is present in an amount ranging from about 0.5% by weight to about 2.5% by weight, based on the total weight of the composition.

[0012] According to embodiment 3, a personal hygiene composition is provided according to the composition and from about 0.1% by weight to about 0.6% by weight, based on the total weight of the composition.

[0013] According to embodiment 4, a personal hygiene composition is provided in accordance with the ee is present in an amount ranging from about 0.25% by weight to about 2.25% by weight, based on the total weight of the deodorant composition.

[0014] According to modality 5, a personal hygiene composition is provided in accordance with and

[0015] According to embodiment 6, a personal hygiene composition is provided according to the selected composition from 40% by weight to approximately 66% by weight, based on the total weight of the composition.

[0016] According to modality 7, a personal hygiene composition is provided in accordance with and Petition 870250084517, dated 09 / 19 / 2025, page 17 / 86 4 / 59 varies from about 1% by weight to about 20% by weight, based on the total weight of the deodorant composition.

[0017] According to embodiment 8, a personal hygiene composition is provided according to any of the embodiments 1 to 7, ee weight, based on the total weight of the deodorant composition.

[0018] According to modality 9, a personal hygiene composition is provided in accordance with and present and 35% by weight, based on the total weight of the deodorant composition.

[0019] According to modality 10, a personal hygiene composition is provided in accordance with and

[0020] According to embodiment 11, a personal hygiene composition containing optional methylheptylglycerin is provided; glyceryl monolaurate; a polyol comprising a diol and a triol; and sodium stearate.

[0021] According to embodiment 12, a personal hygiene composition is provided in accordance with heptylglycerin, which is present in an amount that varies from about 0.5%, and deodorant. Petition 870250084517, dated 09 / 19 / 2025, page 18 / 86 5 / 59

[0022] According to embodiment 13, a personal hygiene composition is provided according to any of embodiments 11 to 12, and from about 0.1% by weight to about 0.6% by weight, based on the total weight of the composition.

[0023] According to embodiment 14, a personal hygiene composition is provided according to any of embodiments 11 to 13, and varies from about 0.25% by weight to about 2.25% by weight, based on the total weight of the deodorant composition.

[0024] According to modality 15, a personal hygiene composition is provided in accordance with the deodorant.

[0025] According to embodiment 16, a personal hygiene composition is provided according to the selected composition of one or more of propylene glycol, butylene glycol and co

[0026] According to embodiment 17, a composition for personal hygiene is provided, according to embodiment 16, wherein the triol comprises glycerin in an amount varying from about 1 co

[0027] According to modality 18, a personal hygiene composition is provided in accordance with and approximately 1 co Petition 870250084517, dated 09 / 19 / 2025, page 19 / 86 6 / 59

[0028] According to embodiment 19, a personal hygiene composition is provided according to any of embodiments 11 to 18, and present in an amount ranging from about 15% by weight to about 35% by weight, based on the total weight of the deodorant composition.

[0029] According to modality 20, a personal hygiene composition is provided according to any of the modalities 11 to 18, and the

[0030] According to embodiment 21, a personal hygiene composition containing a polyol (preferably comprising glycerin) is provided; Methylheptylglycerin in an amount ranging from about 0.5% by weight to about 2.5% by weight, based on the total weight of the deodorant composition; go to approximately 0.6% by weight, based on the total weight of the deodorant composition; Sodium stearate in an amount ranging from about 1% by weight to about 12% by weight, based on the total weight of the deodorant composition; and glyceryl monolaurate in an amount ranging from about 0.25% to about 1% by weight.

[0031] According to modality 22, a personal hygiene composition is provided in accordance with Petition 870250084517, dated 09 / 19 / 2025, page 20 / 86 7 / 59 selected from one or more of glycerin, propylene glycol, butylene glycol and co

[0032] According to embodiment 23, a composition for personal hygiene is provided according to embodiment 22, in which the polyol is present and 81% by weight, based on the total weight of the deodorant composition.

[0033] According to for personal hygiene according to and present and 35% by weight, based on the total weight of the deodorant composition.

[0034] According to modality 25, a personal hygiene composition is provided in accordance with and

[0035] According to embodiment 26, a composition for personal hygiene is provided in accordance with the deodorant in the solid state is formed in a predetermined format.

[0036] According to modality 27, a personal hygiene composition is provided according to the measured 1 hour after application of the personal hygiene composition.

[0037] According to modality 28, a personal hygiene composition is provided according to the hours after application of the personal hygiene composition.

[0038] According to modality 29, a method is provided to reduce and / or prevent bad breath, comprising the application of one or Petition 870250084517, dated 09 / 19 / 2025, page 21 / 86 8 / 59 plus personal hygiene compositions according to modalities 1 to 28 on a skin surface.

[0039] According to modality 30, a method is provided in accordance with co

[0040] According to embodiment 31, a method is provided according to which it is in a solid state when applied to the skin surface.

[0041] According to modality 32, a method is provided according to which the person is selected from: a stick deodorant; a stick antiperspirant; a roll-on deodorant; a roll-on antiperspirant; a lotion; a cream; and a balm.

[0042] According to embodiment 33, a method is provided for manufacturing a composition for personal hygiene comprising: a) Mix a liquid carrier, methylheptylglycerin, xanthan gum, sodium stearate, and glyceryl monolaurate to form a mixture; b) add to the container; and c) cool the for

[0043] According to the agreement, the liquid carrier is present in an amount ranging from about 15% by weight to about 35% by weight, based on the total weight of the mixture.

[0044] According to the agreement co Petition 870250084517, dated 09 / 19 / 2025, page 22 / 86 9 / 59 Heptylglycerin is present in an amount that varies from about 0.5% and

[0045] According to embodiment 36, a method is provided according to which is present and approximately 0.6% by weight, based on the total weight of the mixture.

[0046] According to embodiment 37, a method is provided according to which sodium is present in an amount ranging from about 1% by weight to about 12% by weight, based on the total weight of the mixture.

[0047] According to embodiment 38, a method is provided according to which glyceryl is present ee

[0048] According to modality 39, a method is provided according to the quantity which varies from about 40% by weight to about 66% by weight, co

[0049] According to embodiment 40, a method is provided according to step a) is carried out at a temperature ranging from about 75 °F to about 185 °F.

[0050] According to the agreement carried out and / or if

[0051] According to modality 42, a method is provided in accordance with Petition 870250084517, dated 09 / 19 / 2025, page 23 / 86 10 / 59 c) in which the mixture is cooled to room temperature to form a solid state. DETAILED DESCRIPTION

[0052] The following description of preferred options is merely illustrative and is in no way intended to be a guideline.

[0053] As used throughout the document, ranges are used within the range. Any value within the range can be selected and are incorporated by reference in their entirety. In the event of a conflict, the definition of this disclosure shall prevail.

[0054] Unless otherwise specified, all percentages and quantities expressed in this document and elsewhere in the descriptive report shall be percentages and assets of

[0055] The description of principles of the present invention should be read in connection with the accompanying figures, which should be described in writing. The description of embodiments of the invention, disclosed in this document only for convenience of description and is not intended in any way to be a written description.

[0056] Unless otherwise specified, all percentages and quantities expressed in this document and elsewhere in the descriptive report shall be percentages and Petition 870250084517, dated 09 / 19 / 2025, p. 24 / 86 11 / 59 active ingredient of the material. According to this application, the term “approximately” means +1- 10% of the reference value. According to this application, the term “substantially free” is less than approximately 0.1% by weight based on the total reference value.

[0057] As used herein, the use of a compound co iso no respectively. The symbols 'e *=” mean single bond, double bond and triple bond, respectively. For readability purposes, functional chemical groups are in adjective form; for each of the adjectives, assu noun after it, it should be read as “an alkyl group”.

[0058] Any member of a list of species used to exemplify or define a genus may be mutually different from, overlapping with, or any other explicitly defined species that define or exemplify the genus is open, and it is given that it may be

[0059] All components and elements presented positively in this disclosure may be excluded negatively from the claims. In other words, the personal hygiene compositions of this disclosure may be included in the disclosure. And this disclosure may not be incidental to the ingredient(s) or compound(s) described herein. A Petition 870250084517, dated 09 / 19 / 2025, p. 25 / 86 12 / 59 Non-incidental amount of an ingredient or compound is the amount of that ingredient or compound that is added by itself to the personal care composition. For example, a personal care composition may be substantially free of a non-incidental amount of an ingredient or compound, although such ingredient(s) or compound(s) may be present as part of a raw material that is included co

[0060] Some of the various categories of components identified can co co co caprylyl glycol can be characterized as both a humectant and as uuu

[0061] As used herein, the terms “composition” and “formulation” may be used interchangeably within the descriptive report. As used herein, the term “antiperspirant” refers to a product applied topically to that location. Such a “composition” refers to the reduction or decrease of moisture, perspiration, or humidity in the applied area. As used herein, the term “deodorant” refers to the inhibition and / or reduction of the growth of odor-causing bacteria that give sweat its smell. Such a “composition” provides

[0062] As used herein, the term “free of aluminum-based antiperspirant actives” means that the compositions Petition 870250084517, dated 09 / 19 / 2025, p. 26 / 86 13 / 59 antiperspirants / deodorants of the present disclosure do not comprise aluminum-based antiperspirant actives. For example, aluminum-based antiperspirant actives of the personal hygiene invention to exhibit some personal hygiene effect.

[0063] As used herein, the term “aluminum-free” or “alu-free” includes any aluminum-based antiperspirant. Examples not included are those listed in the U.S. antiperspirant monograph, such as aluminum zirconium sesquichloride, aluminum zirconium octachloride, aluminum zirconium pentachlorohydrex gly, aluminum zirconium tetrachlorohydrex gly, aluminum zirconium propylene glycol, aluminum polyethylene glycol, aluminum propylene glycol, aluminum polyethylene glycol. In such embodiments, the personal hygiene composition may be free of one or more of the foregoing examples of aluminum-based antiperspirant actives.

[0064] As used herein, the term “zirconium-free” or “free of zirconium-based antiperspirant actives” means that the antiperspirant / deodorant composition does not contain any zirconium-based antiperspirant. Non-limiting examples of zirconium-based antiperspirant actives include alu Petition 870250084517, dated 09 / 19 / 2025, page 27 / 86 14 / 59 aluminum and zirconium and aluminum-zirconium glycine complex (e.g., aluminum zirconium trichlorohydrex gly, zirconium pentachlorohydrex gly and alu octochlorohydrex gly). In some embodiments, the personal hygiene composition may be free of one or more of the foregoing examples of zirconium-based antiperspirant actives.

[0065] As used herein, the term “free of zinc-based antiperspirant actives” means that the antiperspirant / deodorant composition does not comprise zinc-based antiperspirant actives. Zinc-based antiperspirant actives are not added to the antiperspirant / deodorant compositions of the invention to exhibit any antiperspirant / deodorant effect. Zinc-based antiperspirants may contain zinc, zinc hydroxide, zinc hydroxide ions with counter-ions and zinc ions. Personal hygiene products may be free of zinc-based antiperspirant actives.

[0066] As used herein, the term “free of iron-based antiperspirant actives” means that the antiperspirant / deodorant composition does not contain iron-based antiperspirants.

[0067] As used herein, the term “free of titanium-based antiperspirant actives” means that the antiperspirant / deodorant composition does not contain titanium-based actives, such as titanium ammonium lactate and the like. In some embodiments, the personal hygiene composition may be free of one or more of the foregoing examples of titanium-based antiperspirant actives. Petition 870250084517, dated 09 / 19 / 2025, p. 28 / 86 15 / 59

[0068] As used herein, the term “free of magnesium-based antiperspirant actives” means that the antiperspirant / deodorant composition does not comprise antiperspirant actives based on, but including, magnesium chloride, magnesium bromide, magnesium fluoride, and organic salts such as various alkyl-substituted carboxylic acids, magnesium oxide, and magnesium hydroxide. As used herein, the term “armpit” or “axillary region” refers to the armpit or axilla of the body. In some embodiments, the personal hygiene composition may be free of one or more of the preceding examples of magnesium-based antiperspirant actives.

[0069] Antiperspirant / deodorant compositions may contain substantial magnesium-based antiperspirant actives, titanium-based antiperspirant actives, free of zirconium-based antiperspirant actives and zinc-based antiperspirant actives. For example, antiperspirant / deodorant compositions may contain approximately 2% by weight or less, approximately 1% by weight or less, approximately 0.5% by weight or less, approximately 0.1% by weight or less, approximately 0.05%, and aluminum-based antiperspirants, magnesium-based antiperspirant actives, titanium-based antiperspirant actives, zirconium-based antiperspirant actives, and zinc-based antiperspirant actives (individually or as an antiperspirant / deodorant). In some embodiments, the antiperspirant / deodorant compositions have approximately 0% by weight or 0% by weight of aluminum-based antiperspirant actives. Petition 870250084517, dated 09 / 19 / 2025, page 29 / 86 16 / 59 zirconium-based antiperspirants and zinc-based antiperspirant actives (individually or cumulatively), based on the total weight of the product.

[0070] Aspects of the invention are directed to antiperspirant / deodorant compositions that provide sweat reduction, being free of aluminum-based antiperspirants, titanium-based antiperspirant actives, zirconium-based antiperspirant actives, and zinc-based antiperspirant actives. The inventors have discovered that certain embodiments of antiperspirant / deodorant compositions containing particular compounds provide about 10% or more, about 15% or more, about 20% or more, about 25% or more, about 30% or more, about 35% or more, about 40% or more, or about 45% or more, being free of aluminum-based antiperspirants and zinc-based antiperspirants.

[0071] Antiperspirant / deodorant compositions as disclosed herein may retard the perspiration process by reducing the amount of perspiration excreted by eccrine and / or apocrine sweat glands. In certain embodiments, the reduction of sweat (when applied to the skin) is approximately 20 to approximately 48%, approximately 20 to approximately 36% or more, approximately 40% or more, approximately 44% or more, or approximately 48% or more, preferably during a 24-hour period after application. For example, the antiperspirant / deodorant composition may provide a reduction in sweat (when applied to the skin) of approximately 20 to approximately 48%, approximately 20 to Petition 870250084517, dated 09 / 19 / 2025, p. 30 / 86 17 / 59 approximately 45%, approximately 20 to approximately 40%, approximately 20 to approximately 36%, approximately 20 to approximately 32%, approximately 20 to approximately 28%; approximately 24 to approximately 48%, approximately 24 to approximately 45%, approximately 24 to approximately 40%, approximately 24 to approximately 36%, approximately 24 to approximately 32%, approximately 24 to approximately 28%, approximately 28 to approximately 40%, approximately 32%, approximately 32% to approximately 40%, approximately 48%, any interval or sub-interval thereof, preferably for a period of 1 hour, 12 hours, 24 hours or 48 hours after application, for example, compared to not using the antiperspirant / deodorant composition. In some forms, the antiperspirant / deodorant compositions described here provide sweat control according to the formula for an 8-hour period, a 24-hour period, or, for example, an antiperspirant / deodorant.

[0072] In some embodiments, the invention provides antiperspirant / deodorant compositions that inhibit harmful bacteria responsible for underarm odor. By reducing underarm sweat, the compositions will reduce the formation of harmful bacteria responsible for bad odor. According to at least one aspect, a method is provided for reducing sweat in the armpit area, for example, by applying the antiperspirant / deodorant compositions to the armpit area. According to co Petition 870250084517, dated 09 / 19 / 2025, p. 31 / 86 18 / 59 aspect, a method is provided to reduce the bad odor caused by excessive sweating using antiperspirant / deodorant compositions according to co

[0073] Antiperspirant / deodorant compositions can be used and applied to the skin. In certain embodiments, the application is to the armpit. In other embodiments, the invention provides a method for reducing sweat by about 10 to about 40%, or about 15 to about 20%, or about 25 to about 30%, or about 30 to about 35%, or about 35 to about 40% for a period of about 1 hour, a period of 2 hours, a period of 3 hours, a period of 4 hours, a period of 6 hours, a period of 8 hours, a period of 12 hours, a period of 18 hours, a period of 24 hours, a period of 36 hours or a period of 48 hours, for example.

[0074] In some embodiments, the invention provides a method for reducing hair sweat for a period of 8 hours, a period of 24 hours, or, for example, antiperspirant / deodorant.

[0075] Suitable components, such as those listed below, may be included in or excluded from formulations for antiperspirant / deodorant care compositions, depending on the specific combination of other components. Petition 870250084517, dated 09 / 19 / 2025, page 32 / 86 19 / 59 hair and / or the use of the formulation (e.g., roll-on, stick, spray, cream)

[0076] The present invention is directed to a deodorant composition. In some embodiments, the deodorant composition may be a spray or a cream (for example, a spray or cream for the armpits). The total composition

[0077] A co more polyols, which may be selected from one or more humectants. In some embodiments, the polyol may comprise a diol. In some embodiments, the polyol may comprise a triol. In some embodiments, the polyol may co

[0078] The polyol may be present in an amount ranging from about 5% by weight to about 10% by weight and subranges between them. In some embodiments, the polyol may be present and 75% by weight based on the total weight of the deodorant composition, including all that may be present, and approximately 72% by weight based on the total weight of the deodorant composition, including all % by weight and subranges in between. Petition 870250084517, dated 09 / 19 / 2025, page 33 / 86 In some embodiments, the polyol may be present in an amount ranging from about 63% by weight to about 69% by weight based on the total weight of the deodorant composition, including all weight percentages and subranges thereafter. In some embodiments, the polyol may be present in an amount ranging from about 65% by weight to about 67% by weight based on the weight and subranges thereafter.

[0079] Diol and triol may be present in a weight ratio ranging from about 0.5:1 to about 15:1 – including all intermediate ratios and subranges. In some embodiments, diol and triol may 1:1 to approximately 7:1 - including all ratios and sub-ranges in between. And weight ratios ranging from approximately 1:1 to approximately 6:1 - including all ratios and sub-ranges in between.

[0080] The diol may be a bio-based diol. The diol may comprise a C3 to C10 diol. In some embodiments, the diol may be selected from pentane diol and co

[0081] Propanediol may comprise one or more of 1,2-propanediol (also known as propylene glycol) and 1,3-propanediol. Butanediol may contain butanediol (also known as propylene glycol). Pentanediol may contain pentanediol, 1,3-pentanediol, 2,3-pentanediol, 1,5-pentanediol.

[0082] The diol may be present in an amount that varies from about 5 co between them. In some embodiments, the diol may be present in a Petition 870250084517, dated 09 / 19 / 2025, p. 34 / 86 21 / 59 quantity ranging from about 10% by weight to about 60% by weight based on the total weight of the deodorant composition - including all percentages and sub-ranges in between. In some embodiments, diol may be present in an amount ranging from about 50% by weight to about 62% by weight based on the total weight of the deodorant composition - including all percentages and sub-ranges in between. In some embodiments, diol may be present in an amount ranging from about 52% by weight to about 60% by weight based on the total weight of the deodorant composition - including all percentages and sub-ranges in between. In some embodiments, diol may be present in an amount ranging from about 54% by weight to about 58% by weight based on all percentages and sub-ranges in between.In some formulations, diol may be present in an amount ranging from approximately 56% by weight to approximately 57% by weight based on the total weight of the deodorant composition – including all percentages and sub-ranges in between.

[0083] In some embodiments, the diol may comprise propylene glycol and may be present from 40% by weight to about 66% by weight based on the total weight of the deodorant, including all percentages and subranges thereafter. In some embodiments, the diol may co Petition 870250084517, dated 09 / 19 / 2025, page 35 / 86 22 / 59 quantity ranging from about 52% by weight to about 60% by weight based on the total weight of the deodorant composition, including all percentages and subranges in between. In some embodiments, the diol may range from about 54% by weight to about 58% by weight based on the total weight of the composition, including all subranges in between. In some embodiments, the diol may comprise propylene glycol and may be present from 54% to 56% by weight, about 57% by weight, based on the total weight of the composition, including all percentages and subranges in between.

[0084] In some embodiments, the diol may comprise a mixture of propylene glycol and butylene glycol, wherein the propylene glycol may be present in an amount ranging from about 4% by weight to about 50% by weight, based on the total weight of the diol, and all percentages and subranges thereafter. In some embodiments, the diol may comprise a mixture of propylene glycol and butylene glycol, wherein the propylene glycol may be present in an amount ranging from about 4% by weight to about 50% by weight ...34% by weight to about 50% by weight, and all percentages and subranges thereafter. Petition 870250084517, dated 09 / 19 / 2025, page 36 / 86 23 / 59 20% by weight based on the total weight of the deodorant composition, including all percentages and sub-ranges thereafter. In some embodiments, the diol may contain propylene glycol, which may be present in an amount ranging from about 38% by weight to about 46% by weight, and butylene glycol may be present. 18% by weight based on the total weight of the deodorant composition, including all percentages and subranges thereto. In some embodiments, the diol may comprise a mixture of propylene glycol and butylene glycol, wherein propylene glycol may be present from about 40% by weight to about 44% by weight and butylene glycol may be present and 16% by weight based on the total weight of the deodorant composition, including all percentages and sub-ranges thereafter. In some embodiments, the diol may contain propylene glycol, which may be present, and approximately 42% of the total weight of the deodorant composition, including all percentages and sub-ranges thereafter.

[0085] Triol may be selected from glycerin. Triol may be present in an amount ranging from about 1% by weight to about 2% by weight in deodorant - including all percentages and sub-ranges in between. In some embodiments, triol may be present in an amount ranging from about 2% by weight to about 19% by weight based on the total weight of the deodorant - including all percentages and sub-ranges in between. In some embodiments, triol may be present in an amount ranging from about 3% by weight to about 18% by weight. Petition 870250084517, dated 09 / 19 / 2025, p. 37 / 86 24 / 59 weight based on the total weight of the deodorant composition - including all percentages and sub-ranges between them. In some embodiments, triol may be present in an amount ranging from about 4% by weight to about 17% by weight based on the total weight of the deodorant composition - including all percentages and sub-ranges between them. In some embodiments, triol may be present in an amount ranging from about 5% by weight to about 16% by weight based on the total weight of the deodorant composition - including all percentages and sub-ranges between them. In some embodiments, triol may be present in an amount ranging from about 6% by weight to about 15% by weight based on all percentages and sub-ranges between them. In some embodiments, triol may be present in an amount ranging from about 7% by weight to about 14% by weight of the deodorant composition - including all percentages and sub-ranges between them.In some embodiments, triol may be present in an amount ranging from about 8% by weight to about 13% by weight based on the total weight of the deodorant – including all percentages and sub-ranges in between. In some embodiments, triol may be present in an amount ranging from about 9% by weight to about 12% by weight of all percentages and sub-ranges in between. In some embodiments, triol may be present in an amount ranging from about 10% by weight to about 11% of the deodorant – including all percentages and sub-ranges in between.

[0086] Without limiting itself to any specific theory, it has been unexpectedly discovered that certain quantities of alkylglyceryl ether and a gum can provide greater sweat reduction. For example, in certain modalities, the composition Petition 870250084517, dated 09 / 19 / 2025, p. 38 / 86 25 / 59 Deodorant may be in stick form, and the amount of glycerin may be from about 1% by weight to about 20% by weight based on the total weight of the deodorant composition—including all percentages and subranges in between. In some embodiments, glycerin may be present in an amount ranging from about 2% by weight to about 19% including all percentages and subranges in between. In some embodiments, glycerin may be present in an amount ranging from about 3% by weight to about 18% by weight based on the total weight of the deodorant composition—including all percentages and subranges in between. In some embodiments, glycerin may be present in an amount ranging from about 4% by weight to about 17% by weight based on the total weight of the deodorant composition including all percentages and subranges in between.In some embodiments, glycerin may be present in an amount ranging from about 5% by weight to about 16% by weight based on the total weight of the subranges between them. In some embodiments, glycerin may be present in an amount ranging from about 6% by weight to about 15% including all percentages and subranges between them. In some embodiments, glycerin may be present in an amount ranging from about 7% by weight to about 14% by weight based on the total weight of the subranges between them. In some embodiments, glycerin may be present in an amount ranging from about 8% by weight to about 13% including all percentages and subranges between them. In some embodiments, glycerin may be present in an amount that varies. Petition 870250084517, dated 09 / 19 / 2025, p. 39 / 86 26 / 59 from approximately 9% by weight to approximately 12% by weight based on the total weight of the deodorant composition – including all percentages and sub-ranges in between. In some embodiments, glycerin may be present in an amount ranging from approximately 10% by weight to approximately 11% by weight based on the total weight of the deodorant composition including all percentages and sub-ranges in between.

[0087] The composition of deodorant may comprise hygroscopic agents or humectants. Generally, humectants can help retain water in the skin and keep it there for longer. Humectants can attract and retain water. They are selected from glycerin (such as refined vegetable glycerin), polyhydric alcohols, low molecular weight polyethylene glycols (PEGs) and polyoxyethylenes. For example, propylene glycol, dipropylene glycol, polypropylene glycol (having three or more units of hexylene glycol, butylene glycol and co-modalities, the polyols and / or humectants are selected from glycerin (e.g. polyethylene glycol, 1,2-pentylene glycol and / or a combination thereof.

[0088] High molecular weight PEGs may, in some cases, be suitable as polyols and / or humectants, including those with an average molecular weight of about 200,000 [Da] to about 7,000,000 [Da], e.g. 1,000,000 [Da] to about 2,500,000 [Da].

[0089] Polyols and / or humectants may be chosen from glycerin, propylene glycol, butylene glycol and 1,3-propanediol, polyglutamic acid, saccharide isomerate and combinations thereof. In some embodiments, the hygroscopic agent or humectant is glycerin. Petition 870250084517, dated 09 / 19 / 2025, page 40 / 86 27 / 59 refined vegetable. In some embodiments, the hygroscopic agent or humectant is polyethylene glycol 600. In some embodiments, the hygroscopic agent or humectant is a combination of polyethylene glycol 600 and vegetable glycerin. Without being limited to any specific theory, in some embodiments harmful bacteria are responsible for the bad odor.

[0090] In some embodiments, the deodorant compositions may and the total percentage / amount of humectant or hygroscopic agent present in the antiperspirant / deodorant compositions may be from about 5 to about 30% by weight, from about 5 to about 25% by weight, from about 5 to about 22% by weight, from about 5 to about 20% by weight, from about 5 to about 16% by weight; from about 8 to about 30% by weight, from about 8 to about 25% by weight, from about 8 to about 22% by weight, from about 8 to about 20% by weight, from about 8 to about 16% by weight, and from 30% to 22% by weight, and from 30% to 22% by weight, and from 18% to 30% by weight, based on the total weight of the deodorant composition. Petition 870250084517, dated 09 / 19 / 2025, p. 41 / 86 28 / 59

[0091] In some embodiments, the deodorant compositions of the invention comprise hygroscopic or humectant agents in about 10% by weight to about 20% by weight of the deodorant composition — including the entire % by weight and subranges thereafter. In some embodiments, the antiperspirant / deodorant compositions of the invention comprise hygroscopic or humectant agents in about 18% by weight of the antiperspirant / deodorant composition — including the entire % by weight and subranges thereafter. In some embodiments, the antiperspirant / deodorant compositions of the invention comprise hygroscopic or humectant agents in about 10% by weight of the composition.

[0092] The deodorant composition may further comprise a fatty acid salt. The fatty acid salt may be selected from an alkali metal, an alkaline earth metal, and amine salts of C14-22 fatty acids.

[0093] In some embodiments, the fatty acid salt may be formed from an alkali metal. The alkali metal may be sodium. In some embodiments, the C14-22 fatty acid salt may be selected from linolenic acid salts and mixtures thereof.

[0094] In some embodiments, the C14-22 fatty acid salt may be selected from sodium stearate, potassium stearate, magnesium stearate, sodium oleate, sodium palmitate, sodium behenate, diethyl stearate, and sodium. Petition 870250084517, dated 09 / 19 / 2025, p. 42 / 86 29 / 59

[0095] In some embodiments, the deodorant composition may be substantially free of hyaluronic acid salts. In some embodiments, the deodorant composition may be substantially free of sodium hyaluronate salt.

[0096] The C14-22 fatty acid salt may be present in an amount ranging from about 1% by weight to about 12% by weight based on the total weight of the composition (including all percentages and subranges thereafter). The fatty acid salt may be present in the composition (known as a gelling agent or structuring agent). The fatty acid salt may be present when the deodorant composition is of stick type, thus imparting a solid state to the deodorant composition. In some cases, it may be present in about 12% of the deodorant composition, including all percentages and subranges thereafter.

[0097] In some embodiments, the C14-22 fatty acid salt may be present and approximately 11 - including all percentages and subranges in between. In some forms, the fatty acid salt may be sodium stearate and may be present in all percentages and subranges in between.

[0098] In some embodiments, the C14-22 fatty acid salt may be present and approximately 10% by weight based on the total weight of the deodorant composition – including all percentages and subranges thereafter. In some embodiments, the fatty acid salt may be sodium stearate and may be Petition 870250084517, dated 09 / 19 / 2025, p. 43 / 86 30 / 59 is present in an amount ranging from approximately 3% by weight to approximately 10% by weight based on the total weight of the deodorant composition, including all percentages and sub-ranges in between.

[0099] In some embodiments, the C14-22 fatty acid salt may be present and approximately 9 including all percentages and subranges thereafter. In some embodiments, the fatty acid salt may be sodium stearate and may be present and approximately 9 including all percentages and subranges thereafter.

[0100] In some embodiments, the C14-22 fatty acid salt may be present and approximately 8% by weight based on the total weight of the deodorant composition including all percentages and subranges thereto. In some embodiments, the fatty acid salt may be sodium stearate and may be present and all percentages and subranges thereto.

[0101] In some embodiments, the C14-22 fatty acid salt may be present and approximately 7% by weight based on the total weight of the deodorant composition including all percentages and subranges thereto. In some embodiments, the fatty acid salt may be sodium stearate and may be present and all percentages and subranges thereto.

[0102] The deodorant composition may comprise a glycerin ester and a fatty acid selected from Cs-18 fatty acids. In some Petition 870250084517, dated 09 / 19 / 2025, p. 44 / 86 In 31 / 59 embodiments, the Cs-is fatty acid can be selected from caprylic, capric, lauric, myristic, palmitic, stearic, oleic, linoleic, and linolenic acids and mixtures thereof. In one embodiment, the fatty acid selected for the glyceryl ester can be lauric acid – resulting in glyceryl monolaurate.

[0103] Glycerin ester and Cs-is fatty acids may be present in an amount ranging from about 0.25% by weight to about 2.25% by weight based on the total weight of the deodorant composition including all percentages and subranges thereafter. In some embodiments, glyceryl monolaurate may be present in an amount ranging from about 0.25% by weight to about 2.25% by weight with percentages and subranges thereafter.

[0104] In some embodiments, the glyceryl ester and Cs-is fatty acids may be present in an amount ranging from about 0.5 percent between them. And present and 2.0 percent including all percentages and subranges between them.

[0105] In some embodiments, glycerin ester and Cs-is fatty acids may be present in an amount ranging from about 0.75% by weight to about 1.75% by weight based on the total weight of the composition between them. The amount present is 1.75% by weight based on the total weight of the deodorant composition, including all percentages and subranges thereafter. Petition 870250084517, dated 09 / 19 / 2025, p. 45 / 86 32 / 59

[0106] In some embodiments, glyceryl ester and C-10 fatty acids may be present in an amount ranging from about 1.0% by weight to about 1.5% by weight based on the total weight of the deodorant composition – including all percentages and subranges in between. In some embodiments, glyceryl monolaurate may be present and from 1.5% by weight based on the total weight of the deodorant composition, including all percentages and subranges in between.

[0107] In some embodiments, glyceryl ester and Ce-ie fatty acids may be present in an amount of about 1.25% and in other embodiments, glyceryl monolaurate may be present in an amount of about 1.25% by weight based on the total weight of the co

[0108] The deodorant composition may comprise a liquid carrier. The liquid carrier may comprise one or more of the following: solvent, diluent, polyol, a humectant, glycerin ester or a mixture of the following: water, alcohols (e.g., ethanol, isopropanol or mixtures thereof) and mixtures thereof. In at least one embodiment, the carrier contains

[0109] The amount of liquid carrier (e.g., water) present in the formulation for personal hygiene can vary, for example, from about 5 to about 90% deodorant – including all % by weight and subranges in between. The liquid carrier content can be selected to produce a co weight of co Petition 870250084517, dated 09 / 19 / 2025, page 46 / 86 33 / 59 any optional materials, are added to the composition in their desired weight percentages.

[0110] In some embodiments, the liquid carrier (e.g., water) may be present in an amount ranging from about 15% and deodorant - including all percentages and subranges thereafter. In some embodiments, water may be present in an amount ranging from about 15% by weight to about 35% by weight based on the total weight of the deodorant - including all percentages and subranges thereafter.

[0111] In some embodiments, the liquid carrier may be present in an amount ranging from about 18% by weight to about 32% by weight based on the total weight of the deodorant composition including all percentages and sub-ranges in between. In some embodiments, water may be present in an amount ranging from about 18% by weight to about 32% by weight based on the total weight of the composition in between.

[0112] In some embodiments, the liquid carrier may be present in an amount ranging from about 21% by weight to about 29% including all percentages and subranges in between. In some embodiments, water may be present in an amount ranging from about 21% by weight to about 29% including all percentages and subranges in between.

[0113] In some embodiments, the liquid carrier may be present in an amount ranging from about 24% by weight to about 26% by weight based on the total weight of the deodorant composition. Petition 870250084517, dated 09 / 19 / 2025, p. 47 / 86 34 / 59 including all percentages and subranges between them. In some modalities, water may be present in an amount ranging from about 24% by weight to about 26% by weight based on the total weight of the co-op between them.

[0114] In some embodiments, the liquid carrier may be present in an amount of approximately 25% by weight based on the total weight of the deodorant composition. In some embodiments, water may be present in an amount of approximately 25% by weight based on the total weight of the composition.

[0115] The deodorant composition may further comprise a thickener. Thickeners may be selected from polysaccharides; carboxylic acid polymers; cross-linked polyacrylate polymers; polymers themselves. Examples of polysaccharides include cellulose, carboxymethyl hydroxyethylcellulose, cellulose acetate, carboxylate propionate, hydroxyethylcellulose, hydroxyethyl ethylcellulose, hydroxypropylcellulose, hydroxypropyl methylcellulose, methyl hydroxyethylcellulose, microcrystalline cellulose, sodium cellulose sulfate and mixtures thereof. In some embodiments, the deodorant compositions of the invention comprise two or more thickeners, such as those selected from hydroxypropyl methylcellulose and cross-linked acrylic acid homopolymer (e.g., Carbopol® Ultrez 30). In some embodiments, the deodorant compositions include two, three, four or five thickeners, or any range or subrange thereof.The thickener can be selected from hydroxypropyl methylcellulose, polyethylene glycols, and others.

[0116] Non-limiting examples of carboxylic acid polymers include acrylic acid-derived monomers, substituted acrylic acids, and salts. Petition 870250084517, dated 09 / 19 / 2025, page 48 / 86 35 / 59 and esters of these acrylic acids and substituted acrylic acids, such as gelling agents include acacia, agar, algin, alginic acid, ammonium alginate, carrageenan, dextrin, gelatin, gellan gum, guar gum, guar chloride, hydroxypropyltrimonium, hectorite, hyaluronic acid, hydrated silica, hydroxypropyl chitosan, hydroxypropyl guar, karaya gum, seaweed, locust bean gum, propylene glycol alginate, sodium carrageenan, tragacanth gum, xanthan gum, and mixtures thereof.

[0117] In certain cases, the deodorant composition may be made of polyacrylic acid, polyvinylpyrrolidone, polyvinyl methyl ether, polyvinyl sulfone, maleic acid copolymer, polyethylene oxide, polydiallylamine, polyethyleneimine, water-soluble cellulose derivatives (e.g., carboxymethylcellulose, methylcellulose, methylhydroxypropylcellulose, hydroxyethylcellulose, hydroxypropylcellulose, sodium salt of cellulose sulfate) and / or starch derivatives (e.g., hydroxypropyl oxide). In such embodiments, the thickeners are selected from hydroxypropyl (sold under the name Carbopol), crosslinked homopolymer of acrylic acid (sold under the name Carbopol® Ultrez 30 polymer) and C10-30 alkyl acrylate crosslinked polymer acrylates (sold under the name Carbopol® Ultrez 20 polymer). Petition 870250084517, dated 09 / 19 / 2025, page 49 / 86 36 / 59

[0118] The deodorant compositions of the invention comprise thickeners of about 1 to about 10% by weight of the total weight of the antiperspirant / deodorant composition. It may include one or more thickeners in an amount of about 0.5% by weight to about 10% by weight, about 0.5% by weight to about 8% by weight, about 0.5% by weight to about 6% by weight, about 0.5% by weight to about 4% by weight, about 0.5% by weight to about 2% by weight, about 0.5% by weight to about 1% by weight; from about 1% by weight to about 10% by weight, from about 1% by weight to about 8% by weight, from about 1% by weight to about 6% by weight, from about 1% to about 4% by weight, from about 1% by weight to about 2% by weight; from about 2% by weight to about 10% by weight, from about 2% by weight to about 8% by weight, from about 2% by weight to about 6% by weight, from about 2% by weight to about 4% by weight;from about 4% by weight to about 10% by weight, from about 4% by weight to about 8% by weight, from about 4% by weight to about 6% by weight; from about 6% by weight to about 10% by weight, from about 6% by weight to about 8% by weight; from about 8% by weight to 10% by weight, or any range or subrange thereof, based on the total weight of the deodorant composition.

[0119] The thickener may comprise a gum. The gum may contain xanthan gum. The gum may be present in an amount ranging from about 0.1% by weight to about 0.6% by weight based on the total weight of the deodorant - including all percentages and subranges thereafter. In some embodiments, the gum may be xanthan gum and be present in an amount ranging from about 0.1% by weight to about 0.6% by weight of the deodorant - including all percentages and subranges thereafter.

[0120] In some embodiments, gum may be present in an amount ranging from about 0.2% by weight to about 0.4% by weight, Petition 870250084517, dated 09 / 19 / 2025, p. 50 / 86 37 / 59 based on the total weight of the deodorant composition - including all percentages and sub-ranges between them. In some embodiments, the gum may be xanthan gum and be present in an amount ranging from about 0.2% by weight to about 0.4% by weight, based on the total weight of the composition and sub-ranges between them.

[0121] In some embodiments, the gum may be present in an amount ranging from about 0.25% by weight to about 0.35% by weight, with percentages and subranges between them. In some embodiments, the gum may be xanthan gum and be present in an amount ranging from about 0.25% by weight, with subranges between them.

[0122] In some embodiments, the gum may be present in an amount of approximately 0.3% by weight, based on the total weight of the deodorant. And be present in an amount of approximately 0.3% by weight, based on the total weight of the co

[0123] The deodorant composition may further comprise an alkylglyceryl ether. The alkylglyceryl ether may comprise one or more of the following: 2-ethylhexylglycerin, isodecylglyceryl ether, glyceryl isostearyl ether, and methylheptylglycerin. In some embodiments, the alkylglyceryl ether is

[0124] Alkylglyceryl ether may be present in an amount ranging from about 0.5% by weight to about 2.5% by weight, based on the total weight of the co- and intermediate subranges. In some embodiments, alkylglyceryl ether may be methylheptylglycerin and be present in an amount ranging Petition 870250084517, dated 09 / 19 / 2025, page 51 / 86 38 / 59 from approximately 0.5% by weight to approximately 2.5% by weight, based on the total weight of the deodorant composition - including all intermediate percentages and sub-ranges.

[0125] In some embodiments, alkylglyceryl ether may be present in an amount ranging from about 1.0% by weight to about 2.0% by weight, based on the total weight of the deodorant composition including all percentages and subranges thereafter. In some embodiments, alkylglyceryl ether may be methylheptylglycerin and be present in an amount ranging from about 1.0% by weight to about 2.0% including all percentages and subranges thereafter.

[0126] In some embodiments, alkylglyceryl ether may be present in an amount of about 1.5% by weight, based on the total weight of the deodorant. And methylheptylglycerin may be present in an amount of about 1.5% by weight, based on the total weight of the deodorant composition including all intermediate percentages and subranges.

[0127] The alkylglyceryl ether and gum may be present in a weight ratio ranging from about 1:1 to about 7:1 – including all intermediate ratios and subranges. In some embodiments, the alkylglyceryl ether and gum may be present in a weight ratio ranging from about 3:1 to about 6:1 – including all ratios and subranges between them. And gum

[0128] In certain preferred forms, the deodorant composition is surprisingly deodorant. Petition 870250084517, dated 09 / 19 / 2025, p. 52 / 86 39 / 59 alkylglyceryl compounds may provide an unexpected improvement in reducing bad breath after application to the user's skin. Furthermore, and / or alternatively, it has been unexpectedly discovered that certain amounts of glycerin in a stick-type deodorant (as discussed in greater detail herein), comprising glycerin in certain amounts, exhibit an unexpected improvement in reducing sweat and / or reducing bad breath after application to the user's skin. In at least one preferred embodiment, these compounds exhibit an unexpected improvement in reducing sweat and bad breath after application to the user's skin. For example, methylheptylglycerin has been found to exhibit an unexpected improvement in reducing bad breath after application to the user's skin. In some embodiments, the compound...

[0129] The deodorant composition may further comprise an additive. In a non-limiting example, the additive may be selected from apricot fragrance, fir needle oil, lavender oil, and lavender oil. The deodorant compositions of the invention comprise fragrances from about 0.01 to about 10% by weight, relative to the total weight of the invention. Petition 870250084517, dated 09 / 19 / 2025, page 53 / 86 40 / 59 deodorants of the invention comprise fragrances of about 0.5 to 1.1% and antiperspirant / deodorant.

[0130] Non-limiting examples of soothing agents include aloe vera, herbal extracts and witch hazel water. Non-limiting examples of antioxidants are, for example, derivatives, butylated hydroxyanisole (BHA), butylated hydroxytoluene (BHT), erythorbic acid, propyl gallate, sodium erythorbate, tertiary butylhydroquinone (TBHQ), rosemary extract and, more preferably, ascorbic acid and its salts.

[0131] Alpha-hydroxy acids, beta-hydroxy acids, polyhydroxy acids or combinations thereof.

[0132] In a non-limiting embodiment, the deodorant composition may include either a C3 to C7 alpha-hydroxy acid or a C4 to C6 alpha-hydroxy acid. In some embodiments, the personal hygiene formulation includes a salt of an alpha-hydroxy acid. The salt of the alpha-hydroxy acid is preferably a sodium salt or a potassium salt. In at least one embodiment, the salt is a sodium salt (i.e., the cation associated with the salt is sodium).

[0133] Non-limiting examples of alpha-hydroxy acids include, but are not limited to, mandelic acid, glycolic acid, citric acid, lactic acid, malic acid, tartaric acid, phytic acid, hydroxycaprylic acid, hydroxycapric acid, glutaric acid, gluconic acid, or a combination of two or more of them. In some embodiments, the alpha-hydroxy acids are selected from mandelic acid, glycolic acid, citric acid, lactic acid, malic acid, tartaric acid, phytic acid, hydroxycaprylic acid, hydroxycapric acid, and combinations thereof. In other embodiments, the alpha-hydroxy acids are citric acid, mandelic acid, glycolic acid, lactic acid. Petition 870250084517, dated 09 / 19 / 2025, page 54 / 86 41 / 59 or a combination of two or more of them. In certain cases, the alpha-hydroxy acid is selected from malic acid, tartaric acid, alpha-hydroxy glutaric acid, gluconic acid, a salt thereof, and a combination of two or more of these. In other cases, the alpha-hydroxy acid or its salt is selected from lactic acid, malic acid, and sodium-D-gluconate. In some embodiments, the alpha-hydroxy acid is lactic acid. The antiperspirant / deodorant compositions of the invention comprise alpha-hydroxy acids from about 0.05 to about 2% by weight, based on the total weight of the antiperspirant / deodorant composition.

[0134] The amount of alpha-hydroxy acid in deodorant compositions may be from about 0.05 to about 2% by weight, from about 0.05 to about 1.8% by weight, from about 0.05 to about 1.6% by weight, from about 0.05 to about 1.4% by weight, from about 0.05 to about 1.2% by weight, from about 0.05 to about 1% by weight, from about 0.05 to about 0.8% and from about 0.1% by weight. 0.1 to about 1.8% by weight, about 0.1 to about 1.6% by weight, about 0.1 to about 1.4% by weight, about 0.1 to about 1.2% by weight, about 0.1 to about 1%, about 0.1 to about 0.6% by weight, about 0.1 to about 0.4% by weight; from about 0.3 to about 2% by weight, about 0.3 to about 1.8% and 1.4 of 1 approximately 2 to approximately 1.6% by weight, approximately 0.6 to approximately 1.4% by weight, approximately 0.6 to approximately 1.2% by weight, approximately 0.6 to approximately 1% by weight; of approximately Petition 870250084517, dated 09 / 19 / 2025, pp. 55 / 86 42 / 59 from 0.9 to about 2% by weight, from about 0.9 to about 1.8% by weight, from about 0.9 to about 1.6% by weight, from about 0.9 to about 1.4% by weight; from about 1.2 to about 2% by weight, from about 1.2 to about 1.8% by weight, from about 1.2 to about 1.6% by weight; from about 1.5 to about 2% by weight, from about 1.5 to about 1.8% by weight, or any range or subrange thereof, based on the total weight of the antiperspirant / deodorant composition. The deodorant compositions of the invention comprise alpha-hydroxy acids from about 0.1 to about 0.15% by weight, from about 0.15 to about 1% and from about the total weight of the deodorant composition.

[0135] Non-limiting examples of beta-hydroxy acids include salicylic acid, propionic acid, beta-hydroxybutyric acid, beta-hydroxy beta-methylbutyric acid, carnitine, and combinations of two or more of these. Beta-hydroxy acids may include salicylic acid, salicylic acid esters, sodium salicylate, beta-hydroxybutanoic acid, tropic acid, tretinocanic acid, beta-hydroxy acids obtained from white willow bark extract and / or wintergreen leaves, and co-hydroxy acid(s) comprise(s) salicylic acid, sodium salicylate, beta-hydroxy acids from willow bark extract or co-hydroxy acids.

[0136] Non-limiting examples of polyhydroxy acids may include, but are not limited to, gluconolactone, gluconic acid, galactose, lactobionic acid, or cohydroxy acids are gluconolactone, lactobionic acid, or combinations thereof. For example, the polyhydroxy acid glucanodeltalactone may be. Petition 870250084517, dated 09 / 19 / 2025, pp. 56 / 86 43 / 59

[0137] The amount of polyhydroxy acid in deodorant compositions may be from about 0.05 to about 2% by weight, from about 0.05 to about 1.8% by weight, from about 0.05 to about 1.6% by weight, from about 0.05 to about 1.4% by weight, from about 0.05 to about 1.2% by weight, from about 0.05 to about 1% by weight, from about 0.05 to about 0.8% and from about 0.1% by weight. 0.1 to about 1.8% by weight, about 0.1 to about 1.6% by weight, about 0.1 to about 1.4% by weight, about 0.1 to about 1.2% by weight, about 0.1 to about 1% by weight, about 0.1 to about 0.8% by weight, about 0.1 to about 0.6% by weight, about 0.1 to about 0.4% by weight; from about 0.3 to about 2% by weight, about 0.3 to about 1.8% and 1.4% to about 1.6% by weight, about 0.6% to about 1.4% by weight, about 0.6% to about 1.2% by weight, about 0.6% to about 1% by weight; about 0.9% to about 2% by weight, about 0.9% to about 1.8% by weight, about 0.9% to about 1.6% by weight, about 0.9% to about 1.4% by weight; about 1.2% to about 2% by weight, about 1.2% to about 1.8% by weight, about 1.2% to about 1.6% by weight; about 1.5% to about 2% by weight, about 1.5% to about 1.8% by weight, or any range or subrange thereof, co

[0138] In some embodiments, the deodorant compositions of the invention comprise antifoaming agents or preservatives. The deodorant compositions may comprise preservatives selected from caprylyl glycol, phenoxyethanol, butylated hydroxytoluene (BHT), acid Petition 870250084517, dated 09 / 19 / 2025, p. 57 / 86 44 / 59 ethylenediaminetetraacetic acid (EDTA), ethylhexylglycerin, citric acid, benzoic acid, and combinations thereof. In some embodiments, the antifoaming agent or preservative is caprylyl glycol. Caprylyl glycol may also be called 1,2-octanediol.

[0139] The deodorant compositions of the invention comprise antifoaming agents or preservatives from about 0.1% by weight to about 10% by weight, based on the total weight of the deodorant composition including all quantities and subranges in between.

[0140] In some embodiments, the antiperspirant / deodorant compositions comprise optional ingredients such as fragrances, surfactants, vegetable oils, antioxidants, antibacterial agents, deodorizing agents, skin-soothing agents, vitamins, pH adjusters, polymers or combinations thereof.

[0141] The invention comprises surfactants. In some embodiments, the surfactants are selected from nonionic surfactants, anionic surfactants, cationic surfactants, and amphoteric / zwitterionic surfactants. Examples of anionic surfactants include sodium sulfate or a combination of two or more of these. For example, the anionic surfactant may be selected from ammonium lauryl sulfate, ammonium lauryl ether sulfate, and a combination of two or more of these.

[0142] The amount of anionic surfactants in the deodorant composition can be from about 0.5 to about 10% by weight, from about 0.5 to about 10% by weight, from about 0.5 to about 6% by weight, from about 0.5 to about 4% by weight. Petition 870250084517, dated 09 / 19 / 2025, p. 58 / 86 45 / 59 weight, about 0.5 to about 2% by weight, about 0.5 to about 1% by weight; from about 1 to about 10% by weight, about 1 to about 8% by weight, about 1 to about 6% by weight, about 1 to about 4% by weight, about 1 to about 2%, about 2 to about 8% by weight, about 2 to about 6% by weight, about 2 to about 4%, from 4 to about 8%, from 6 to about 10%, from 8 to 10% total deodorant composition.

[0143] Amphoteric surfactants in antiperspirant / deodorant compositions may uu Preferably, the amphoteric surfactant comprises a betaine surfactant. Non-limiting examples of betaine surfactants include coca lauryl carboxymethylcellulose (CLC) or u

[0144] The amount of amphoteric surfactants in the deodorant composition can be from about 0.5 to about 10% by weight of the total composition, or from about 0.5 to about 10% by weight, or from about 0.5 to about 8%, or about 4%, or about 1%. Petition 870250084517, dated 09 / 19 / 2025, page 59 / 86 46 / 59 approximately 8% by weight, approximately 1 to approximately 6% by weight, approximately 1 to approximately 4 of 10% by weight, approximately 2 to approximately 8% by weight, approximately 2 to approximately 6 ee based on the total weight of the deodorant composition.

[0145] In some embodiments, the surfactants are nonionic surfactants. In some embodiments, the nonionic surfactants include, but are not limited to, secondary alcohol ethoxylates, polyoxyethylene stearyl ethers, polyoxyethylene ethers, a mixture of high molecular weight saturated fatty alcohols, primarily cetyl alcohol and stearyl alcohol. Antiperspirant / deodorant compositions may include a nonionic surfactant mixture including two or more fatty alcohol ethoxylates, each having a polyethylene oxide chain length of at least 2. Preferred fatty alcohol ethoxylates generally have a fatty alcohol chain length of C12 to C24, a degree of unsaturation of 0-2, and a polyethylene oxide chain length of 2 to 150 ethylene oxide units. For example, fatty alcohol ethoxylates can have the general formula: CH3--(CH2)x--CH2--O-(CH2--CH2--O--)yH- , where X=10-20, Y=2-150.In some cases, the fatty alcohol ethoxylate mixture includes at least one fatty alcohol ethoxylate with a long polyethylene oxide chain length and at least one fatty alcohol ethoxylate with a short polyethylene oxide chain length. Suitable long-chain fatty alcohol ethoxylates have a polyethylene oxide chain length greater than 20, preferably 21 to 150, more preferably 21 to 100. For example, the fatty alcohol ethoxylate may be a stearyl ether of... Petition 870250084517, dated 09 / 19 / 2025, pp. 60 / 86 47 / 59 polyoxyethylene with a structure according to the chemical formula: CH3(CH2)i6-CH2-(O-CH2-CH2)n-OH with an average of n being 2 to 20, respectively.

[0146] Preferred long-chain fatty alcohol ethoxylates include Steareth-100 (100 indicates the polyethylene oxide chain length) and Steareth-21. Other long-chain fatty alcohol ethoxylates may be used, for example, Ceteth-100, Oleth-100, Myreth-100, and Beheneth-100. These surfactants have a preferred HLB range of 15 to 8. Suitable short-chain fatty alcohol ethoxylates include, for example, Steareth-2, Steareth-10, Ceteth-20, Steareth-20, u

[0147] The nonionic surfactants of the deodorant composition may be selected from polyoxyethylene ethers, such as polyoxyethylene stearyl ether compounds. The polyoxyethylene ethers may comprise a mixture of high molecular weight saturated fatty alcohols, such as cetyl alcohol and stearyl alcohol, and ethylene oxide. The polyoxyethylene ethers may be selected from Ceteareth-2, Ceteareth-3, Ceteareth-4, Ceteareth-5, Ceteareth-6, Ceteareth-7, Ceteareth-8, Ceteareth-9, Ceteareth-10, Ceteareth-11, Ceteareth-12 and a combination of two or more thereof. Examples of polyoxyethylene stearyl ether compounds include Steareth-2, Steareth-4, Steareth-6, Steareth-7, Steareth-21, Steareth-10, Steareth-11, Steareth-13, Steareth-15, Steareth-20 or secondary alcohol compounds sold under the trade names Tergitol®, available from Dow™.

[0148] The amount of non-ionic surfactants (e.g., polyoxyethylene ethers and / or polyoxyethylene stearyl ethers) in the composition Petition 870250084517, dated 09 / 19 / 2025, pp. 61 / 86 48 / 59 antiperspirant / deodorant may contain from about 0.5 to about 10% by weight, co a co polyoxyethylene ethers and / or polyoxyethylene stearyl ethers) in an amount of about 0.5 to about 10% by weight, about 0.5 to about 8 of 4 of 1 of 8 and and weight; from about 6 to about 10% by weight, from about 6 to about 8% by weight; from about 8 to 10% by weight. 0.1 to about 5% by weight, based on the total weight of the deodorant composition. The deodorant compositions of the invention comprise surfactants of about 1 to about 3% by weight, based on the total weight of the composition.

[0149] The deodorant compositions of the invention may comprise Tergitol® at approximately 2% by weight, based on the total weight of the invention. Petition 870250084517, dated 09 / 19 / 2025, pp. 62 / 86 49 / 59 antiperspirants / deodorants of the invention comprise Tergitol® in approximately 5

[0150] In some embodiments, the deodorant compositions of the invention comprise antioxidants of about 1 to about 5% by weight, the amount of antioxidant present in the deodorant composition may be about 1 to about 5% by weight, about 1 to about 4% by weight, about 1 to about 3% by weight, about 1 to about 2% by weight; about 2 to about 5% by weight, about 2 to about 4% by weight, about 2 to about 3%, or any range or subrange thereof, based on the total weight of the deodorant composition. In some embodiments, the deodorant compositions of the invention contain hydroxytoluene, pentaerythrityl tetra-di-t-butyl hydroxyhydrocinnamate, or combinations thereof. Pentaerythrityl tetra-di-t-butyl hydroxyhydrocinnamate is commercially available under the name Tinogard TT™ from Ciba / BASF. In some embodiments, the deodorant compositions of the invention comprise witch hazel at approximately 2% by weight relative to the total weight of the composition.

[0151] The pH of the antiperspirant / deodorant composition may be in the range of 4 to 11, or 7.5 to 10.5, or 8 to 10, or 8.5 to 9.5, or 9 to 9.5 or 9 to 10.

[0152] The deodorant composition may be in a solid state, or the term "solid state" may refer to the deodorant composition having a self-supporting structure that can be contained within a container. In the solid state, the deodorant composition Petition 870250084517, dated 09 / 19 / 2025, pp. 63 / 86 50 / 59 can be used in a stick deodorant (compared to a liquid roll-on deodorant).

[0153] Stick deodorant can be applied by gliding it over the user's skin (compared to roll-on application). During gliding application, portions of the deodorant's composition are deposited onto the user's skin and provide protection against bad breath to that area of ​​skin. During gliding application, the skin...

[0154] The deodorant composition of the present invention can be manufactured by mixing the aforementioned components to create a mixture. The mixture can be heated to an elevated temperature above the elevated temperature, which can range from about 75°F to about 185°F - including all the temperatures to the temperature or if "semi-solid" can refer to a composition that is capable of flowing and does not retain a self-supporting structure and maintains a predetermined shape if

[0155] A predetermined quantity of the mixture can then be deposited and cooled to at least room temperature, thus solidifying.

[0156] In a non-limiting embodiment, the mixture may consist of xanthan; a glycerin ester and a C14-22 fatty acid; and the alkaline salt of a C14-22 fatty acid. The mixture may also comprise the additive mixture. Petition 870250084517, dated 09 / 19 / 2025, pp. 64 / 86 51 / 59 EXAMPLES

[0157] The following experiments tested the impact on deodorant effectiveness based on the presence of methylheptylglycerin (“MHG”) and xanthan gum (“XG”). The formulation of each example is presented below in Table 1 - each numerical value represents a percentage by weight (%) and Example 1

[0158] An experiment was carried out to test the impact of the reduction of the present invention - the formulations are presented below in Table 1. Table 1 Ingredients Comp. Ex. 1 (% by weight) Comp. Example 2 (% by weight) Example 1 (% by weight) Example 2 (% by weight) Water 25.35 24.5 24.5 24.5 Butylene Glycol - - - 42.2 Propylene Glycol 56.28 56.73 56.43 14.23 Sodium Stearate 6.03 6.0 6.0 6.0 Glyceryl Monolaurate 1.26 1.25 1.25 1.25 Glycerin 10.05 10.0 10.0 10.0 Sodium Hyaluronate Solution 1% 1.01 - - - MHG - 1.5 1.5 1.5 XG - - 0.3 0.3 Aloe Vera 0.02 0.02 0.02 0.2

[0159] Each of the Comparative Examples 1 (Ex. Comp. 1), Comparative Example 2 (Ex. Comp. 2), Example 1 (Ex. 1) and Example 2 (Ex. 2) were then subjected to a bad breath test to measure the deodorant effectiveness of each for and sub by trained judges using an odor intensity scale of 0 to 10 (0 = no bad breath, 5 = moderate bad breath, 10 = extremely strong bad breath). Individuals with a bad breath score of 5 or more at the start of the study (if Petition 870250084517, dated 09 / 19 / 2025, pp. 65 / 86 52 / 59 to participate in the test. After washing the underarm area and applying the tested products, bad breath was evaluated after a period of 12 hours, 24 hours, and 48 hours.

[0160] The test results are presented below in Table 2. Table 2 Reference Baseline Bad Odor Score 12 Hours 24 Hours 48 Hours Comp. Ex. 1 6.31 2.17 3.17 5.23 Comp. Ex. 2 6.31 1.49 2.48 4.54 Ex. 1 6.31 0.84 1.85 3.87 Ex. 2 6.58 1.12 1.92 3.14

[0161] As demonstrated by the data described in Table 2 (above), it was surprisingly observed that the two compositions performed unexpectedly in reducing bad breath for each recorded time period, up to the 48-hour period. Specifically, not only did the compositions perform surprisingly well over the hours, but the deodorant compositions continued to outperform the others up to 48 hours. Example 2

[0162] After discontinuation of all axillary antiperspirants, male subjects (1 / 2 with shaved armpits, 1 / 2 unshaven), aged between 18 and 65 years, attended the testing center for consent and screening. Seventy-two (72) male subjects who met the study criteria were included on the day. Sixty-four (64) male subjects with collections of Petition 870250084517, dated 09 / 19 / 2025, pp. 66 / 86 53 / 59 sweaters with at least 100 mg of sweat per armpit were allowed to continue and received a final number in order from highest to lowest sweating.

[0163] Individuals who received a final number participated in u individuals returned from day 2 to day 8 for axillary assessment, supervised washing, and application of the test article. On Day 8, subjects also participated individuals were presented for axillary assessment and sweat collection (24 hours after the 8th application). On Day 10, individuals were presented for axillary assessment and sweat collection (48 hours after the 8th application). Sixty-one (61) subjects completed the study. Two (2) subjects dropped out.

[0164] The subjects' perspiration was induced by having them sit outdoors in the morning for sweat collection. This method of sweat collection is permitted by the guidelines for Efficacy Testing of Over-the-Counter Antiperspirant Products, June 2003.1

[0165] The data were analyzed following FDA guidelines for efficacy testing of over-the-counter antiperspirant products. The Ratio Method was used to determine the % reduction in sweat for a co (Ex. 3) and Table 3 (below). Table 3 Ingredient Ex. 3 (% by weight) Propylene Glycol 58.8 Water 26.9 Glycerin 10 Sodium Stearate 6 Glyceryl Monolaurate 1.3 Ascorbic Acid 0.05 Petition 870250084517, dated 09 / 19 / 2025, pp. 67 / 86 54 / 59 Aloe Vera Gel - Spray Dry 0.03

[0166] The Wilcoxon Signed Rank test was used to determine the significance level for a 20% reduction in sweat (Z < 0.8) and for a 30% reduction in sweat (Z < 0.7) at p <Nível de significância de 0,05. Também foi usado para deter horas.

[0167] Based on the results of the Wilcoxon Signed-Rank Test, the exemplary composition of the present invention (Ex. 3) was significant No. 8 when tested against Z <Hipótese 0,8 (redução de 20% do suor) e o Z<Hipótese 0,7 (redução de 30% do suor). Além disso, o Ex. 3 foi significativa para Z<Hipótese 0,8 (redução de 20% do suor). As reduções percentuais médias de suor, os intervalos de confiança de 95% e os níveis de significância derivados do teste de classificação por postos sinalizados sem distribuição são apresentados na Tabela 4 (abaixo). Table 4 Evaluation % Sweat Reduction vs. Untreated Axilla 95% Confidence Interval Significance Level Ha: Z<0.8 20% reduction Ha: Z<0.7 30% reduction Ha: Z<1.0 Overall Efficacy 1 hour after Application #8 49.17% 44.03% to 54.30% <0.05* <0.05* <0.05* 24 hours after Application #8 30.97% 25.68% to 36.25% <0.05* >0.05 <0.05* 48 hours after Application #8 14.20% 7.16% to 21.23% >0.05 >0.05 <0.05* Significantly effective at p<0.05

[0168] As illustrated by the data described in Table 3 (above), u hour, 30.97 Example 3

[0169] After a 21-day conditioning period that required discontinuation of all underarm antiperspirants, the individuals ( Petition 870250084517, dated 09 / 19 / 2025, pp. 68 / 86 55 / 59 men, half women), aged between 18 and 65 years, attended the testing center for consent and screening. Sixty (60) individuals who met the study criteria were included. Individuals were assigned to randomization after meeting the baseline acceptance criteria.

[0170] On Day 1, individuals participated in a supervised wash as described in Table 5 (below). Table 5 Ingredients Ex. 4 (% by weight) Propylene Glycol 56.3 Water 25.4 Glycerin 10.1 Sodium Stearate 6 Glyceryl Monolaurate 1.3 Sodium Hyaluronate Solution 1 Aloe Vera Gel - Spray Dried 0.03

[0171] Individuals returned from Day 2 to Day 8 for axillary assessment, washing, and also participated in a sweat collection, 1 hour after the 8th application. On Day 9, individuals were referred for axillary assessment and sweat collection (24 hours after the 8th application). Fifty-one (51) individuals, 23 men and 28 women, completed the study. Nine (9) subjects were induced to drop out by sitting them in a room maintained at 100±2 F and 30%-40% of u

[0172] The data were analyzed following FDA guidelines for efficacy testing of over-the-counter antiperspirant products. The Ratio Method was used to determine the % reduction in sweat for a co-treated group. The Wilcoxon Signed Rank test was used to determine the level Petition 870250084517, dated 09 / 19 / 2025, pp. 69 / 86 56 / 59 significance for a 20% reduction in sweat (Z < 0.8) at p <Nivel de significância de 0,05. Também foi usado para determinar o requisito geral de eficácia (Z<1,0).

[0173] Based on the results of the Wilcoxon Signed-Rank Test, an exemplary composition of the present invention (Ex. 4) was significantly more effective in reducing perspiration 1 hour after Application No. 8 when tested against Z <Hipótese 0,8 (redução de 20% do suor). A co significativamente mais eficaz na redução da transpiração em 24 horas contra o Z<Hipótese 1.0 (eficácia geral). As reduções percentuais médias de suor, os intervalos de confiança de 95% e os níveis de significância derivados do teste de classificação por postos sinalizados sem distribuição são apresentados na Tabela 6 (abaixo). Table 6 Evaluation % Sweat Reduction vs. Untreated Axilla 95% Confidence Level Significance Range Ha: Z<0.8 20% reduction Ha: Z<1.0 Overall Efficacy 1 hour after Application #8 22.05% 13.15% to 30.95% <0.05* <0.05* 24 hours after Application #8 9.89% 3.23% to 16.46% >0.05 <0.05* Significantly effective at p<0.05

[0174] Specifically, an exemplary composition of the present invention demonstrated sweat reductions of 22.05% in 1 hour and 9.89% in 24 hours. Example 4

[0175] A 3-week at-home consumer evaluation was conducted to assess u li Co Specifically, 320 volunteers aged between 18 and 65 were instructed to apply the deodorant composition to their armpits in the same way. Petition 870250084517, dated 09 / 19 / 2025, pp. 70 / 86 57 / 59 who would normally use a deodorant and / or antiperspirant composition over a period of 3 weeks. Table 7 Ex. 5 (% by weight) Water 22-27 Butylene glycol 13-16 Propylene glycol 40-45 Sodium stearate 5-7.4 Glyceryl monolaurate 1-1.6 Glycerin 8-12 Methylheptylglycerin 1.25-2 Xanthan gum 0.1-0.5 Aloe vera 0.01-0.1 Fragrance 1.1

[0176] After the 3-week period, each volunteer answered a questionnaire, which was professionally evaluated to determine the outcome of the consumer assessment at home. Specifically, 88% of the volunteers indicated u Example 5 did not provide protection against moisture, and 1% of volunteers were unsure whether the composition of Example 5 provided protection against moisture. Example 5

[0177] A monograph study was conducted to evaluate one aspect of the invention. The formulation of the Exe Deodorant Composition Deodorant Sample 5, except that the Composition of Deodorant Sample 5 Table 8 Ex. 6 (% by weight) Water 22-27 Butylene glycol 13-16 Propylene glycol 40-45 Petition 870250084517, dated 09 / 19 / 2025, pp. 71 / 86 58 / 59 Sodium stearate 5-7.4%, Glyceryl monolaurate 1-1.6%, Glycerin 8-12%, Methylheptylglycerin 1.25-2%, Xanthan gum 0.1-0.5%, Aloe vera 0.01-0.1%

[0178] Specifically, a dose of 0.45-0.55 g / axilla was applied, along with supervised washing with a non-antimicrobial soap and application of the Exemplary Deodorant Composition 6. Volunteers returned from Day 2 to Day 8 for axillary assessment, supervised washing, and application of the Exemplary Deodorant Composition 6.

[0179] On Day 8, volunteers participated in a sweat collection, 1 hour after the 8th application. On Day 9, volunteers presented for axillary assessment and sweat collection (24 hours after the 8th application). Individuals' sweating was induced by having them sit in a room maintained at 100±2 F and 30%-40% relative humidity (RH).

[0180] The data were analyzed following FDA guidelines for efficacy testing of over-the-counter antiperspirant products. The Ratio was used to determine the % reduction in sweat for the Exe Deodorant Composition. The Wilcoxon Signed Rank test was used to determine the significance level for the 20% reduction in sweat (Z < 0.8) at p <Nível de significância de 0,05, para redução de suor de 30 o requisito geral de eficácia (Z<1.0) em p<Nível de significância de 0,05. Um resu Table 9 Evaluation of Percentage Reduction in Sweat vs. Untreated Confidence Level Significance Level Z < 0.8 (20% reduction in sweat) Z < 0.7 (30% reduction in sweat) Z < 1 (Overall Efficacy) 1 hour after application #8 31.5% -1.57% -64.57% <0.05 >0.05 <0.05* 24 hours after application #8 11.96% 3.12% -20.8% >0.05 >0.05 <0.05* Petition 870250084517, dated 09 / 19 / 2025, pp. 72 / 86 59 / 59 *Significantly effective at p<0.05

[0181] Although the invention has been described with respect to specific examples, including currently preferred modes of carrying out the invention, those skilled in the art will understand that there are numerous variations and permutations of the compositions, products and / or systems described above and of the scope of the present invention. Thus, the spirit and scope of the invention shall be limited to the appended claims. Petition 870250084517, dated 09 / 19 / 2025, pp. 73-86

Claims

1 / 3 CLAIMS 1. Composition for personal hygiene, characterized in that it comprises: an alkylglyceryl ether; xanthan gum; a glycerin ester and a C8-18 fatty acid; a polyol comprising glycerin, and an alkaline salt of a C14-22 fatty acid.

2. Personal hygiene composition according to claim 1, characterized in that alkylglyceryl ether is present in an amount ranging from about 0.5% by weight to about 2.5% by weight, based on the total weight of the personal hygiene composition.

3. Personal hygiene composition, according to claim 1 or 2, characterized in that xanthan gum is present in an amount ranging from about 0.1% by weight to about 0.6% by weight, based on the total weight of the personal hygiene composition.

4. A composition for personal hygiene, according to any of the preceding claims, characterized in that the glycerin ester and a C8-18 fatty acid are present in an amount ranging from about 0.25% by weight to about 2.25% by weight, based on the total weight of the composition for personal hygiene.

5. A composition for personal hygiene, according to any of the preceding claims, characterized in that the composition for personal hygiene is a deodorant composition, the deodorant composition being in a solid state at room temperature.

6. Composition for personal hygiene, characterized in that it comprises: methylheptylglycerin; xanthan gum; Petition 870250084517, dated 09 / 19 / 2025, page 80 / 86 2 / 3 glyceryl monolaurate; a polyol comprising a diol and a triol; and sodium stearate.

7. A composition for personal hygiene, according to claim 6, characterized in that methylheptylglycerin is present in an amount ranging from about 0.5% by weight to about 2.5% by weight, based on the total weight of the personal hygiene composition; in that xanthan gum is present in an amount ranging from about 0.1% by weight to about 0.6% by weight, based on the total weight of the personal hygiene composition; in that glyceryl monolaurate is present in an amount ranging from about 0.25% by weight to about 2.25% by weight, based on the total weight of the personal hygiene composition; and / or in that sodium stearate is present in an amount ranging from about 1% by weight to about 12% by weight, based on the total weight of the personal hygiene composition.

8. Composition for personal hygiene, characterized in that it comprises: a polyol comprising glycerin; methylheptylglycerin in an amount ranging from about 0.5% by weight to about 2.5% by weight, based on the total weight of the deodorant composition; xanthan gum in an amount ranging from about 0.1% by weight to about 0.6% by weight, based on the total weight of the deodorant composition; sodium stearate in an amount ranging from about 1% by weight to about 12% by weight, based on the total weight of the deodorant composition; and glyceryl monolaurate in an amount ranging from about 0.25% by weight to about 2.25% by weight, based on the total weight of the deodorant composition, Petition 870250084517, dated 09 / 19 / 2025, p. 81 / 86 3 / 3 wherein the personal care composition is in the form of a deodorant composition; optionally wherein the personal hygiene composition is in solid form and has a predetermined shape.

9. Method for reducing bad odor, characterized in that it comprises: applying the personal care composition, as defined in any one of claims 1 to 8, to a skin surface; optionally wherein the personal hygiene composition is selected from: a stick deodorant; a stick antiperspirant; a roll-on deodorant; a roll-on antiperspirant; a lotion; a cream; and a balm.

10. Method for manufacturing a composition for personal hygiene, characterized in that it comprises: a) mixing methylheptylglycerin, glycerin, xanthan gum, sodium stearate and glyceryl monolaurate to form a mixture; b) adding a predetermined quantity of the mixture to a container; and c) cooling the mixture in the container to room temperature to form a solid state. Petition 870250084517, dated 19 / 09 / 2025, pp. 82 / 86